Clinical trial
Methylphenidate in Children and Adolescents With Pervasive Developmental…
NCT00025779 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00025779 |
|---|---|
| Title | Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders |
| Official title | Methylphenidate for Hyperactivity and Impulsiveness in Children and Adolescents With Pervasive Developmental Disorders |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Attention Deficit Disorder With Hyperactivity, Autistic Disorder, Pervasive Development Disorders |
| Intervention type | Drug |
| Interventions | methylphenidate, guanfacine |
| Enrollment | 60 |
| Start date | Oct 1, 2001 |
| Primary completion | Nov 1, 2003 |
| First posted | Oct 24, 2001 |
| Last update posted | Jul 28, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: